Semmax Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.15K | Hold |
14
| – | – | ﹤0.01% | 286 |
|
|
2025
Q1 | $3.52K | Hold |
14
| – | – | ﹤0.01% | 298 |
|
|
2024
Q4 | $3.71K | Hold |
14
| – | – | ﹤0.01% | 270 |
|
|
2024
Q3 | $3.77K | Hold |
14
| – | – | ﹤0.01% | 265 |
|
|
2024
Q2 | $3.75K | Hold |
14
| – | – | ﹤0.01% | 298 |
|
|
2024
Q1 | $2.1K | Hold |
14
| – | – | ﹤0.01% | 301 |
|
|
2023
Q4 | $2.27K | Hold |
14
| – | – | ﹤0.01% | 306 |
|
|
2023
Q3 | $2.31K | Buy |
+14
| New | +$2.31K | ﹤0.01% | 269 |
|
|
2022
Q4 | $3K | Hold |
14
| – | – | ﹤0.01% | 218 |
|
|
2022
Q3 | $3K | Sell |
14
-807
| -98% | -$173K | ﹤0.01% | 208 |
|
|
2022
Q2 | $190K | Sell |
821
-100
| -11% | -$23.1K | 0.08% | 91 |
|
|
2022
Q1 | $150K | Sell |
921
-72
| -7% | -$11.7K | 0.06% | 107 |
|
|
2021
Q4 | $168K | Sell |
993
-189
| -16% | -$32K | 0.06% | 108 |
|
|
2021
Q3 | $223K | Sell |
1,182
-138
| -10% | -$26K | 0.08% | 102 |
|
|
2021
Q2 | $224K | Buy |
1,320
+19
| +1% | +$3.22K | 0.07% | 104 |
|
|
2021
Q1 | $184K | Buy |
+1,301
| New | +$184K | 0.07% | 103 |
|